Back to Journals » Vascular Health and Risk Management » Volume 12

SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives

Total article views   Abstract views HTML views PDF downloads Totals
24,602 Dovepress* 6,374 3,624+ 2,556 9,998
PubMed Central* 0 14,604 2,103 14,604
Totals 6,374 18,228 4,659 24,602
*Since 4 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 2 0 0 1 3

View citations on PubMed Central and Google Scholar